Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, you do need to keep eating on Mounjaro. The medicine reduces appetite significantly, but eating too little (or skipping meals entirely) can make side effects worse, cause muscle loss, and undermine the results you're working towards. Tirzepatide is licensed for use alongside a reduced-calorie diet, not instead of food altogether. That distinction matters clinically and practically. A question our prescribers hear most weeks is some version of "I'm just not hungry — do I still have to eat?" The honest answer is: yes, but it doesn't have to be much, and what you eat matters more than it did before. As a prescription-only medicine, tirzepatide is assessed individually by a clinician before it can be prescribed, appetite changes are part of that ongoing clinical picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The starter dose of tirzepatide (2.5 mg) is low by design. Its main job is to let your body adapt to the medicine before the dose increases. Even at this stage, many people notice a meaningful drop in hunger within days. The temptation is to take that as permission to eat as little as possible. It isn't. Eating too little at this stage (fewer than roughly 800–1,000 kcal a day for most adults) can make nausea, fatigue, and dizziness considerably worse, because the stomach is emptying more slowly and an empty stomach with a slowed gut is a miserable combination.
Small, frequent meals work better here than two or three large ones. Something light every few hours keeps blood sugar stable and gives the digestive system less to deal with at once. Dry, plain foods (plain crackers, toast, rice) tend to sit more easily when nausea is at its worst. The full guide to eating during Mounjaro treatment covers practical meal ideas, but the core principle at this stage is: eat something, even if it's not much.
Hydration matters just as much as food. Nausea can put people off drinks as well as meals, but dehydration compounds fatigue and dizziness quickly. Plain water, diluted squash, and light broth all count.
By the time doses climb toward 5 mg and above, appetite suppression tends to be more pronounced. This is where the real risk of under-eating emerges. When the body is in a significant calorie deficit and protein intake is low, it does not draw exclusively on fat stores, it draws on muscle too. Losing muscle alongside fat slows metabolism and makes weight regain more likely if treatment ever stops.
Protein is the single most important dietary factor to keep an eye on during this phase. NHS nutritional guidance and the clinical evidence base for GLP-1 treatment both point to adequate protein intake as the key to preserving lean mass. A rough practical target for most adults on a reduced-calorie diet is 1.2–1.6 g of protein per kilogram of body weight per day, though your prescriber or a dietitian can give you a personalised figure. If fitting that into reduced portions feels difficult, protein shakes on Mounjaro are an option many people use to top up without adding much volume.
Fibre is the second priority: vegetables, legumes, and wholegrains keep the gut moving and support the microbiome, which matters when gastric motility has changed. Heavily processed, high-fat, high-sugar foods often trigger reflux and nausea more readily on Mounjaro than before, not because the medicine forbids them, but because a slower gut tolerates them less well.
If you want a more detailed breakdown of whether healthy eating is strictly required on Mounjaro, that page works through the evidence and practical reality honestly.
Some people find their appetite partially returns between doses, particularly in the early weeks at a new dose level. Others find it stays suppressed throughout. Neither is inherently a problem, but both need managing. If hunger returns noticeably and regularly, that is worth mentioning at your clinical review, it can be a signal that the current dose is not quite right for you. If you are rarely hungry at all and struggling to meet basic nutritional needs, that equally needs a conversation with your prescriber.
Occasionally people go the other way and find a high-calorie meal leads to discomfort, bloating, or reflux. Overeating on Mounjaro is less common but it does happen, the guide on what to do if you overeat is useful reading if that has happened to you. On the other side, feeling unexpectedly hungry on Mounjaro is also more common than people expect, and that page addresses it directly.
Coffee and caffeinated drinks deserve a brief mention: they are not banned, but on an already-sensitised stomach they can increase nausea and reflux for some people. The detail on coffee and Mounjaro is worth reading if that is part of your morning routine.
For a broader picture of how tirzepatide fits into a weight management approach, the weight-loss treatment overview covers the licensed options available through a regulated UK pharmacy. The NHS provides clear patient-level guidance on tirzepatide on its tirzepatide medicines page, including advice on eating and side effects during treatment. NHS Live Well healthy weight guidance also sets out general principles on balanced eating that sit well alongside any medical weight-management programme. On balance, if you are considering starting treatment, the cost context for Mounjaro in the UK is another practical thing to understand early on.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.